These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1653594)

  • 1. Lisinopril versus atenolol: decrease in systolic versus diastolic blood pressure with converting enzyme inhibition.
    Pannier BE; Garabedian VG; Madonna O; Fouchard M; Darne B; Safar ME
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):775-81. PubMed ID: 1653594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antihypertensive effect of lisinopril compared to atenolol in patients with mild to moderate hypertension.
    Bolzano K; Arriaga J; Bernal R; Bernardes H; Calderon JL; Debruyn J; Dienstl F; Drayer J; Goodfriend TL; Gross W
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S43-7. PubMed ID: 2442551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lisinopril combined with atenolol in the treatment of hypertension. Swedish Lisinopril Study Group.
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):457-61. PubMed ID: 1720846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lisinopril versus atenolol for mild to moderate essential hypertension.
    Beevers DG; Blackwood RA; Garnham S; Watson M; Mehrzad AA; Admani K; Angell-James JE; Feely M; Kumar S; Husaini MH
    Am J Cardiol; 1991 Jan; 67(1):59-62. PubMed ID: 1846057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension.
    Pool JL; Gennari J; Goldstein R; Kochar MS; Lewin AJ; Maxwell MH; McChesney JA; Mehta J; Nash DT; Nelson EB
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S36-42. PubMed ID: 2442550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
    Os I; Hotnes T; Dollerup J; Mogensen CE
    Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antihypertensive efficacy of lisinopril compared to metoprolol in moderate to severe hypertension.
    Zachariah PK; Bonnet G; Chrysant SG; DeBacker G; Goldstein R; Herrera J; Lindner A; Materson BJ; Maxwell MH; McMahon FG
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S53-8. PubMed ID: 2442553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of lisinopril and atenolol in black and Indian patients with mild-to-moderate essential hypertension.
    Seedat YK; Parag KB
    S Afr Med J; 1987 Feb; 71(3):149-53. PubMed ID: 3027905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antihypertensive therapies by noninvasive techniques.
    Graettinger WF; Lipson JL; Klein RC; Cheung DG; Weber MA
    Chest; 1989 Jul; 96(1):74-9. PubMed ID: 2544352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lisinopril dose-response relationship in essential hypertension.
    Gomez HJ; Cirillo VJ; Sromovsky JA; Otterbein ES; Shaw WC; Rush JE; Chrysant SG; Gradman AH; Leon AS; MacCarthy EP
    Br J Clin Pharmacol; 1989 Oct; 28(4):415-20. PubMed ID: 2556172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the cardiac and hemodynamic effects of lisinopril and atenolol in patients with hypertension: therapeutic implications.
    Zusman RM; Christensen DM; Higgins J; Boucher CA
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):216-22. PubMed ID: 1381012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antihypertensive effect of lisinopril compared with nifedipine in patients with mild to severe essential hypertension.
    Eber B; Brussee H; Rotman B; Kramer R; Klein W
    Angiology; 1992 Jun; 43(6):482-9. PubMed ID: 1317687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressures.
    Whelton A; Miller WE; Dunne B; Hait HI; Tresznewsky ON
    J Clin Pharmacol; 1990 Dec; 30(12):1074-80. PubMed ID: 2177062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lisinopril: dose-peak effect relationship in essential hypertension.
    Cirillo VJ; Gomez HJ; Salonen J; Salonen R; Rissanen V; Bolognese JA; Nyberg R; Kristianson K
    Br J Clin Pharmacol; 1988 May; 25(5):533-8. PubMed ID: 2841960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patients.
    Hansson L; Forslund T; Höglund C; Istad H; Lederballe-Pedersen O; Kristinsson A; Segaard E; Svensson A; Aärynen M; Wahrenberg H; Wennersten G; Kjellström T
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):1-5. PubMed ID: 8797128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators.
    Chrysant SG; Weder AB; McCarron DA; Canossa-Terris M; Cohen JD; Gunter PA; Hamilton BP; Lewin AJ; Mennella RF; Kirkegaard LW; Weir MR; Weinberger MH
    Am J Hypertens; 2000 Nov; 13(11):1180-8. PubMed ID: 11078178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Smidt UM; Chen JW; Sato A; Parving HH
    Scand J Clin Lab Invest; 1997 Aug; 57(5):427-34. PubMed ID: 9279969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.